VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DXR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DXRDaxor Corporation
$10.11$51M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDXRBalance Sheet

Daxor Corporation (DXR) Balance Sheet

30Y historyFree accessUpdated daily

The company maintains a clean capital structure with a 0.00 debt-to-equity ratio, though liquidity remains constrained with a current ratio of 0.17 as of 2024Q4.

DXR Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets018.57K25.88K37.84K764.5K032.74K36.72K45.27K2.62M2.49M324.75K278.58K2.3M81.69M86.99M70.98M74.48M100.46M77.37M58.91M207.73K140.33K225.01K606.19K126.37K74.53K300K400K1.2M
Cash & Short-Term Investments0000710.7K617.8K001.09M2.18M2.46M00059.63K57.74K277.09K2.55M2.03M2.84M93K5.08K3.32K13.04K431.95K18.44K67.78K100K100K100K
Cash Only0000710.7K617.8K001.09M2.18M2.46M00059.63K57.74K277.09K2.55M2.03M2.84M93K5.08K3.32K13.04K431.95K18.44K67.78K100K100K100K
Short-Term Investments000000000000000000000000000000
Accounts Receivable09.68K14.2K17.23K30.7K29.3K32.74K33.71K45.27K45.87K33.38K324.75K144.68K2.3M23.3M32.56M16.87M2.83M10.5M174.11K1.15M156.39K137.01K211.98K174.24K107.93K6.75K200K300K1.1M
Days Sales Outstanding-1.660.15-17.8-4.28-3.81-103.91-13.4-16.339.12-1.64-29.24-4.57-399.016.66K7.53K3.65K586.552.05K42.75312.5646.8515.828.6483.8652.824.28243.33219143.39
Inventory00000000000000301.53K363.63K454.41K426.83K255.83K171K191.86K000000000
Days Inventory Outstanding--------------168.67182.4235.31301.89196.25110.3252.99---------
Other Current Assets08.89K000-647.1K0357K1.09M2.57M2.46M215.34K1.24M-2.3M23.29M32.51M10.91M337.48K12.76M7.22M230.63K000000000
Total Non-Current Assets46.01M36.61M34.84M30.22M24.22M15.67M13.97M17.24M18.14M17.97M18.38M44.48M45.99M54.03M4.04M4.21M4.21M2.35M2.1M795.96K653.02K55.1M47.7M40.91M42.55M49.04M35.23M400K400K400K
Property, Plant & Equipment000000000000004M4.17M4.17M2.31M2.06M763.8K620.87K290.57K303.37K338.88K276.12K321.3K366.27K400K400K400K
Fixed Asset Turnover--------------0.32x0.38x0.40x0.76x0.91x1.95x2.16x4.19x10.43x7.97x2.75x2.32x1.57x0.75x1.25x7.00x
Goodwill000000000000000000000000000000
Intangible Assets000000000000000000000000000000
Long-Term Investments46M36.61M34.84M30.22M24.22M15.67M13.97M17.24M18.14M17.97M18.38M44.48M45.99M54.03M55.8M53.88M63.84M68.34M74.92M66.97M57.25M54.81M47.4M40.57M42.27M48.72M34.87M000
Other Non-Current Assets9.86K000000-17.24M-18.14M-17.97M-18.38M-44.48M-45.99M0-60.33M-62.84M-74.43M-76.37M-90.61M-82.22M-57.21M-55.1M-47.7M-40.91M-42.55M-49.04M-35.23M-400K-400K-400K
Total Assets46.01M36.63M34.87M30.26M24.98M16.55M14.2M17.63M19.31M20.62M20.89M46.05M47.39M56.33M85.72M91.2M75.19M76.82M102.56M78.17M59.57M55.93M48.3M41.57M43.54M49.58M35.85M44.1M41.3M37.3M
Asset Turnover0.01x0.06x0.99x-0.01x-0.10x-0.17x-0.01x-0.05x-0.05x0.09x-0.36x-0.09x-0.24x-0.04x0.01x0.02x0.02x0.02x0.02x0.02x0.02x0.02x0.07x0.06x0.02x0.02x0.02x0.01x0.01x0.08x
Asset Growth %25.6%5.06%15.23%21.13%50.92%16.56%-19.43%-8.72%-6.37%-1.29%-54.63%-2.84%-15.86%-34.29%-6%21.29%-2.13%-25.09%31.21%31.23%6.5%15.79%16.18%-4.52%-12.17%38.3%-18.72%6.78%10.72%-1.06%
Total Current Liabilities122.59K110.33K103.1K62.44K806.42K707K78.75K72.5K75K7.82K9.14K15.9K27.76K049.26M43.9M27.21M32.97M47.21M32.53M20.82M89.16K183.05K112.48K52.85K42.43K127.34K100K200K100K
Accounts Payable0110.33K103.1K62.44K87.4K80K78.75K72.5K75K7.82K9.14K15.9K27.76K0525.17K436.54K533.63K604.42K498.21K412.97K512.02K89.16K183.05K112.48K52.85K42.43K127.34K100K200K100K
Days Payables Outstanding--212.5220.9631.8542.5478.2998.56136.8210.3110.59---293.77218.98276.33427.5382.18266.43141.41---------
Short-Term Debt0000715.8K627K000000000000000000000000
Deferred Revenue (Current)00000000-1.02M-2.18M-2.44M00038.67K51.92K46.9K33.35K7.42K2.75K90.47K000000000
Other Current Liabilities122.59K0003.23K00-72.5K-75K-7.82K-9.14K-15.9K-27.76K4.43M-650.93K-3.48M-1.52M-3.28M-505.63K-415.72K-602.49K-89.16K-183.05K-112.48K-52.85K-42.43K-127.34K-100K-200K-100K
Current Ratio-0.17x0.25x0.61x0.95x-0.42x0.51x0.60x335.00x272.35x20.43x10.04x-1.66x1.98x2.61x2.26x2.13x2.38x2.83x2.33x0.77x2.00x11.47x2.98x0.59x3.00x2.00x12.00x
Quick Ratio-0.17x0.25x0.61x0.95x-0.42x0.51x0.60x335.00x272.35x20.43x10.04x-1.65x1.97x2.59x2.25x2.12x2.37x2.82x2.33x0.77x2.00x11.47x2.98x0.59x3.00x2.00x12.00x
Cash Conversion Cycle--------------6.53K7.49K3.61K460.941.86K-113.36224.14---------
Total Non-Current Liabilities122.59K729.97K755.66K1.23M3.02M170.69K1.34M4.45M4.33M2.8M3.85M21.36M20.25M21.22M243.95K300.06K346.86K390.29K430.6K3.48M7.08M4.11M2.5M1.43M1M1.78M2.44M2.1M2.5M1.6M
Long-Term Debt112K729.97K755.66K1.23M3.02M170.69K1.34M4.45M4.33M2.8M3.85M21.36M20.25M10.68M14.05M27.39M11.16M13.48M3.78M00000000000
Capital Lease Obligations000000000000000000000000000000
Deferred Tax Liabilities00000000000006.11M0000000000000000
Other Non-Current Liabilities10.6K000000-4.45M-4.33M-2.8M-3.85M-21.36M-20.25M4.43M-14.05M-27.39M-11.16M-13.48M-3.78M00000000000
Total Liabilities122.59K840.3K858.76K1.29M3.83M877.69K1.44M4.56M5.55M5.28M6.47M21.47M21.02M21.22M49.51M44.2M27.56M33.36M47.64M32.53M20.82M16.05M11.88M8.03M8.21M10.9M6.57M8.8M8.4M5.5M
Total Debt112K729.97K755.66K1.23M3.02M170.69K1.34M4.45M4.33M2.8M3.85M21.36M20.25M10.68M14.05M27.39M11.16M13.48M3.78M3.48M7.08M4.11M2.5M1.43M1M1.78M2.44M2.1M2.5M1.6M
Net Debt112K729.97K755.66K1.23M2.31M-447.11K1.34M4.45M3.25M617.87K1.39M21.36M20.25M10.68M13.99M27.33M10.88M10.94M1.75M644.23K6.99M4.11M2.5M1.42M568.05K1.76M2.38M2M2.4M1.5M
Debt / Equity0.00x0.02x0.02x0.04x0.14x0.01x0.11x0.34x0.32x0.18x0.27x0.87x0.77x0.30x0.39x0.58x0.23x0.31x0.07x0.08x0.18x0.10x0.07x0.04x0.03x0.05x0.08x0.06x0.08x0.05x
Debt / EBITDA0.01x0.35x0.90x0.20x0.55x----1.91x-----3.17x1.50x0.68x0.31x-----2.34x1.46x-2.10x-2.29x
Net Debt / EBITDA0.01x0.35x0.90x0.20x0.42x----0.42x-----3.16x1.46x0.55x0.14x-----1.33x1.44x-2.00x-2.14x
Interest Coverage575.44x7.30x6.72x72.47x243.19x-204.98x-3.45x-10.05x-41.21x39.31x-49.06x-19.16x-40.13x-12.02x-1.72x-4.66x-1.57x-1.56x------------
Total Equity45.89M35.79M34.01M28.97M21.15M15.68M12.77M13.06M13.76M15.34M14.43M24.58M26.37M35.11M36.22M47M47.63M43.46M54.92M45.64M38.74M39.88M36.42M33.55M35.33M38.67M29.28M35.3M32.9M31.8M
Equity Growth %28.2%5.24%17.4%36.95%34.94%22.79%-2.27%-5.06%-10.34%6.35%-41.31%-6.79%-24.9%-3.04%-22.94%-1.32%9.58%-20.86%20.33%17.79%-2.85%9.51%8.56%-5.04%-8.64%32.08%-17.05%7.29%3.46%-0.93%
Book Value per Share9.207.397.343.385.243.983.053.493.654.013.756.546.428.588.5811.0911.129.8412.019.878.358.647.847.197.578.275.867.066.586.36
Total Shareholders' Equity45.89M35.79M34.01M28.97M21.15M15.68M12.77M13.06M13.76M15.34M14.43M24.58M26.37M35.11M36.22M47M47.63M43.46M54.92M45.64M38.74M39.88M36.42M33.55M35.33M38.67M29.28M35.3M32.9M31.8M
Common Stock55.35K54.09K53.17K53.17K53.17K53.17K53.17K53.17K53.17K53.17K10.75M10.75M10.74M53.16K53.16K53.16K53.16K53.16K53.16K53.16K53.1K53.1K53.1K53.1K53.1K53.1K53.1K000
Retained Earnings34.8M25.63M25.09M24.79M19.61M14.86M16.57M17.06M8.48M10.38M10.24M10.57M13M47.47M24.74M32.98M32.24M32.16M23.49M12.84M13.63M14.59M15.17M16.25M16.44M16.14M16.2M16.3M16.7M19.2M
Treasury Stock-4.5M-4.5M-4.83M-8.77M-10.62M-10.62M-14.86M-14.86M-14.97M-14.72M-14.28M-13.42M-12.73M-12.41M-11.83M-11.6M-11.36M-10.87M-8.42M-6.02M-5.78M-5.64M-5.17M-4.92M-4.81M-4.81M-4.46M-3.7M00
Accumulated OCI34.8M0024.79M19.61M14.86M017.06M00000012.57M14.89M16.02M11.46M29.21M28.38M20.54M000-1.95M-919.41K-861.16K-800K-700K-700K
Minority Interest000000000000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Investment Portfolio Market Sensitivity

Verified Source

Metrics are mathematically derived from official filings.

SEC 8-K (2025Q4)

Asset Base Expansion Through Investments

According to reported financial statements, Daxor's total assets grew from $16.7M in 2021Q2 to $46.0M by 2025Q4, a trend primarily driven by the appreciation of its internal investment portfolio rather than organic growth from its medical device operations or core diagnostic kit sales.

The trajectory of the balance sheet appears decoupled from the underlying medical business, as asset growth is largely a function of market-driven investment gains. Investors should monitor whether this asset accumulation provides a sustainable buffer or if it merely masks the lack of commercial traction in the BVA-100 platform.

Minimal Leverage Preserves Financial Flexibility

Based on the most recent 2025Q4 filings, Daxor maintains a debt-to-equity ratio of 0.00, reflecting a debt-free capital structure that provides significant financial optionality despite the ongoing operational challenges and the lack of meaningful revenue generation from its primary medical instrumentation business segment.

The absence of debt suggests that the company is not reliant on external credit markets to fund its R&D or operational burn. This conservative leverage profile appears to be a strategic choice, allowing the firm to avoid interest rate exposure on its liabilities while it attempts to navigate the slow adoption of its diagnostic technology.

Persistent Liquidity Constraints and Ratios

As indicated by historical balance sheet data, the company's current ratio has remained consistently low, fluctuating between 0.03 and 0.35 over the past several years, which suggests a structural reliance on liquidating investment assets to meet short-term operational obligations rather than relying on internal cash flow.

The consistently low current ratio implies that the company may face liquidity pressure if its investment portfolio experiences significant volatility or if market conditions prevent the timely liquidation of holdings. This warrants further investigation into the specific composition of current assets and the ease with which they can be converted to cash to support ongoing medical operations.

Investment Portfolio as Operational Proxy

Based on the company's 1940 Act filing status, the balance sheet is fundamentally distorted by the inclusion of a large investment portfolio, which makes traditional metrics like return on assets or liquidity ratios potentially misleading indicators of the medical device business's actual health and commercial viability.

The reliance on investment gains to bolster the balance sheet creates a non-obvious risk where the company's financial stability is tied to market performance rather than product adoption. Analysts should be cautious, as a downturn in the utility or preferred stock sectors could rapidly erode the capital base that currently funds the company's research and development efforts.

DXR — Frequently Asked Questions

Quick answers to the most common questions about buying DXR stock.

What are the total assets of Daxor Corporation (DXR)?

As of 2025, Daxor Corporation (DXR) had total assets of $46.0M including $0.0M in current assets.

How much debt does Daxor Corporation (DXR) have?

Daxor Corporation (DXR) carries total debt of $0.1M, offset by $0.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Daxor Corporation?

Daxor Corporation (DXR) has total shareholders' equity (book value) of $45.9M ($9.20 book value per share). Book value represents the net worth of the company belonging to common stock holders.